Epigenetic silencing of MEIS2 in prostate cancer recurrence

BACKGROUND: Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, resulting in overdiagnosis and overtreatment of clinically insignificant tumors. Thus, to improve the management of PC, novel biomarkers are urgently needed. RESULTS: In this study, we integrated genome-wide...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Epigenetics
Main Authors: Nørgaard, Maibritt, Haldrup, Christa, Bjerre, Marianne Trier, Høyer, Søren, Ulhøi, Benedicte, Borre, Michael, Sørensen, Karina D.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805635/
https://ncbi.nlm.nih.gov/pubmed/31640805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0742-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker